Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 64,672 shares at $9.14 ($590K) on 2018-07-09, disclosed to the SEC on 2018-07-10.
Open-market sale of $590k MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.14 | 15,366 | $140K | 23.8% |
| 2 | $9.14 | 15,366 | $140K | 23.8% |
| 3 | $9.14 | 10,981 | $100K | 17.0% |
| 4 | $9.14 | 10,981 | $100K | 17.0% |
| 5 | $9.05 | 5,989 | $54K | 9.2% |
| 6 | $9.05 | 5,989 |
| $54K |
| 9.2% |
| Total | $9.12 avg | 64,672 | $590K | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-06-29 | $238K | — | Filing → |